Results 91 to 100 of about 4,391 (150)

Agonistic GITR treatment enhances antitumor immune responses and suppresses tumor progression in pancreatic ductal adenocarcinoma. [PDF]

open access: yesJ Gastroenterol
Robatel S   +14 more
europepmc   +1 more source

Erythropoietin receptor on cDC1s dictates immune tolerance. [PDF]

open access: yesNature
Zhang X   +31 more
europepmc   +1 more source

Targeting donor XCR1+ and CD11b+ dendritic cells prevents Th1- and Th17-dependent GVHD within the gastrointestinal tract.

open access: yesBlood
Takahashi S   +15 more
europepmc   +1 more source

Thymic myeloid cells are heterogenous and include a novel population of transitional dendritic cells. [PDF]

open access: yesJ Exp Med
Vobořil M   +6 more
europepmc   +1 more source

Loss of SHP-1 in CD11c<sup>+</sup> cells impairs anti-tumor immunity. [PDF]

open access: yesFront Immunol
Galán M   +10 more
europepmc   +1 more source

Claudin 1-mediated positioning of DC1 to mTECs is essential for maintenance of central tolerance. [PDF]

open access: yesJ Exp Med
Březina J   +24 more
europepmc   +1 more source

Myeloid dendritic cell subsets characterise muscle in patients with inclusion body myositis and correlate with the IFN-γ pathway and effector T cell markers. [PDF]

open access: yesAnn Rheum Dis
Kirou RA   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy